<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04762927</url>
  </required_header>
  <id_info>
    <org_study_id>URIS202101</org_study_id>
    <nct_id>NCT04762927</nct_id>
  </id_info>
  <brief_title>Metric Properties of de Morton Mobility Index</brief_title>
  <acronym>DEMMIURIS</acronym>
  <official_title>Metric Properties of de Morton Mobility Index in Rehabilitation Patients With Musculoskeletal Impairments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Rehabilitation Institute, Republic of Slovenia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Rehabilitation Institute, Republic of Slovenia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metric properties (convergent validity, predict validity, known-groups validity,&#xD;
      responsiveness, floor and ceiling effects, minimal clinically important difference) of the de&#xD;
      Morton Mobility Index (DEMMI) in patients with musculoskeletal impairments undergoing&#xD;
      impatient rehabilitation will be investigated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Convergent validity of DEMMI will be assessed in terms of correlations with the other outcome&#xD;
      measures. Known-groups validity will be demonstrated by differences in DEMMI scores between&#xD;
      patients who were not able to walk and those who were able to walk with or without walking&#xD;
      aid. Predictive validity of DEMMI at admission for functional independence at discharge from&#xD;
      rehabilitation will be estimated. The minimal clinically important difference of DEMMI,&#xD;
      responsiveness and floor or ceiling effects will also be estimated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>de Morton Mobility Index - change</measure>
    <time_frame>Approximately 30 days (difference between admission and discharge)</time_frame>
    <description>DEMMI is a unidimensional 15-item measure of mobility for adults</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ten-meter Walk Test</measure>
    <time_frame>Approximately 30 days (difference between admission and discharge)</time_frame>
    <description>10mWT assesses comfortable walking speed over the distance of 10 meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute Walk Test - change</measure>
    <time_frame>Approximately 30 days (difference between admission and discharge)</time_frame>
    <description>6mWT assesses assess aerobic capacity and endurance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Independence Measure - change</measure>
    <time_frame>Approximately 30 days (difference between admission and discharge)</time_frame>
    <description>FIM is an 18-item two-dimensional instrument that explores physical and psychosocial functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-3L - change</measure>
    <time_frame>Approximately 30 days (difference between admission and discharge)</time_frame>
    <description>EQ-5D-3L is a patient-reported instrument for measuring HRQOL</description>
  </secondary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Musculoskeletal Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with musculoskeletal impairments with or without impairments of peripheral nerves&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admission to inpatient rehabilitation&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  associated impairments of the central nervous system or other severe health conditions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aleksander Zupanc, PT, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Rehabilitation Institute, Republic of Slovenia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Metka MohariÄ‡, MD, PhD</last_name>
    <phone>+386 1 4758441</phone>
    <email>strokovni.direktor@ir-rs.si</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Rehabilitation Institute, Republic of Slovenia</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksander Zupanc, PT, MSc</last_name>
      <phone>+386 1 4758231</phone>
      <email>aleksander.zupanc@ir-rs.si</email>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DEMMI</keyword>
  <keyword>outcome measurement</keyword>
  <keyword>physiotherapy</keyword>
  <keyword>clinimetric properties</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

